We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZA icon
1476
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.25B
$2.3M 0.01%
90,238
-24,535
-21% -$622K
KIE icon
1477
State Street SPDR S&P Insurance ETF
KIE
$642M
$2.29M 0.01%
78,123
+39,807
+104% +$1.15M
KWEB icon
1478
KraneShares CSI China Internet ETF
KWEB
$5.65B
$2.29M 0.01%
47,862
+12,144
+34% +$565K
GME icon
1479
GameStop
GME
$8.53B
$2.29M 0.01%
424,288
+2,460
+0.6% +$13.9K
VSS icon
1480
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
$2.29M ﹤0.01%
21,153
+10,423
+97% +$1.11M
MDIV icon
1481
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$428M
$2.29M ﹤0.01%
118,461
-3,731
-3% -$72.5K
XYZ
1482
Block Inc
XYZ
$50.1B
$2.28M ﹤0.01%
97,196
+24,660
+34% +$510K
AXON
1483
Axon Enterprise
AXON
$49.1B
$2.28M ﹤0.01%
90,633
+19,835
+28% +$485K
HQL
1484
abrdn Life Sciences Investors
HQL
$605M
$2.28M ﹤0.01%
109,312
+14,039
+15% +$284K
AX icon
1485
Axos Financial
AX
$5.89B
$2.28M ﹤0.01%
95,980
+21,213
+28% +$502K
GDXJ icon
1486
VanEck Junior Gold Miners ETF
GDXJ
$7.87B
$2.28M ﹤0.01%
68,218
-22,551
-25% -$751K
KRC icon
1487
Kilroy Realty
KRC
$4.5B
$2.28M ﹤0.01%
30,285
+982
+3% +$72.3K
IGPT icon
1488
Invesco AI and Next Gen Software ETF
IGPT
$1.22B
$2.27M ﹤0.01%
121,737
-9,351
-7% -$170K
KXI icon
1489
iShares Global Consumer Staples ETF
KXI
$1.07B
$2.27M ﹤0.01%
44,468
-662
-1% -$34K
TREX icon
1490
Trex
TREX
$5.15B
$2.27M ﹤0.01%
134,368
+68,292
+103% +$1.15M
SHOO icon
1491
Steven Madden
SHOO
$3.59B
$2.27M ﹤0.01%
85,067
+4,047
+5% +$103K
CEM
1492
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$2.26M ﹤0.01%
29,589
-1,633
-5% -$131K
ECON icon
1493
Columbia Emerging Markets Consumer ETF
ECON
$338M
$2.25M ﹤0.01%
86,255
+43,250
+101% +$1.13M
BAH icon
1494
Booz Allen Hamilton
BAH
$8.65B
$2.25M ﹤0.01%
69,168
-10,234
-13% -$368K
IVOV icon
1495
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.36B
$2.25M ﹤0.01%
+39,446
New +$2.22M
IBKC
1496
DELISTED
IBERIABANK Corp
IBKC
$2.25M ﹤0.01%
27,568
-5,970
-18% -$474K
CUB
1497
DELISTED
Cubic Corporation
CUB
$2.25M ﹤0.01%
48,498
+8,879
+22% +$426K
UNT
1498
DELISTED
UNIT Corporation
UNT
$2.24M ﹤0.01%
119,680
-14,635
-11% -$291K
VRNS icon
1499
Varonis Systems
VRNS
$4.98B
$2.24M ﹤0.01%
180,747
-285
-0.2% -$3.27K
JPIN icon
1500
JPMorgan Diversified Return International Equity ETF
JPIN
$372M
$2.24M ﹤0.01%
39,868
+19,756
+98% +$1.09M

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.